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Primary cell cultures from 18 human pheochromocytomas were maintained 
in culture for 10 to 12 days and characterized. The cell yields ranged from 1.0 
to 60.1 x lo6 cells/g wet weight of tissue. Cell size, as determined by histoflu- 
orescent microscopy, varied as much as seven-fold among cells derived from 
a given tumor and ten-fold between cells from all tumors. Cell catecholamine 
content, norepinephrine (NE) plus epinephrine, ranged from 0.4 to 89.5 nmoll 
lo6 cells at day 5 in culture and did not correlate with catecholamine content 
of the tissue from which the cells were obtained. Cell catecholamine content 
decreased with time in culture, but this decrease could not be related to a 
change in cell viability, the type of media used, an inability to convert dopa- 
mine to NE, or an alteration in the uptake of 3H-NE. Cellular uptake of 1.0 pM 
’H-NE varied as much as 230-fold between all cell dispersions. The basal and 
acetylcholine stimulated release of both preloaded 3H-NE and the endo- 
genous catecholamines was quite variable. There was no correlation between 
the release rate, either basal or stimulated, of preloaded 3H-NE and the 
endogenous catecholamines. This study represents the largest existing data 
base on culturing cells from these tumors and describes many of the morpho- 
logic and biochemical characteristics of this cell system. 
The investigation of human pheochromocytoma has 
been confined primarily to in vivo studies (Manger and 
Gifford, 1977; Winkler and Smith, 1972), while the in 
vitro investigation of this adrenomedullary tumor has 
been confined almost exclusively to the PC12 rat cell 
line (Greene and Tischler, 1982). Since Costero et al. 
(1965) observed the pulsations of human pheochromwy- 
toma cells in culture, there have been only 11 other 
reports using cultured cells from this tumor. The total 
number of tumors reported cultured to date is 25. These 
studies have reported the presence of cellular catechol- 
amines (Lamberts et al., 19841, a decline of cellular cat- 
echolamines on day 21 compared to day 0 (Tischler et 
al., 19841, an erratic decline of catecholamines in the 
culture medium (Cabana et al., 1964; Nishihira et al., 
1980), and a loss or alteration of storage granules with 
time in culture (Misugi et al., 1968; Kadin and Bensch, 
1971). The latter effect appeared to be partially antago- 
nized by the presence of nerve growth factor (Pfragner 
et al., 1984). It has also been reported that nerve growth 
factor induced cell process formation (Tischler et al., 
1976; Pfragner and Walser, 1980); that these cells exhib- 
ited short duration, all-or-nothing action potentials (Tis- 
chler et al., 1976); that acetylcholine and various 
ionophores stimulated the release of preloaded 3H-nor- 
epinephrine (3H-NE) and endogenous catecholamines as 
well as opioid peptides (Wilson et al., 1981); and that 
these cells produced neuropeptide Y (Tischler et al., 1985) 
as well as neurotensin and VIP-like immunoreactivity 
(Tischler et aI., 1984). These reports have been sporadic 
and have examined only one or two cell parameters, 
usually with cells derived from only one or two tumors. 
This report presents the largest existing single data 
base (n = 18) concerned with the morphologic and bio- 
chemical characterization of cultured human phewhro- 
mocytoma cells. In addition to codirming some 
previously reported observations, we present the follow- 
ing new observations: 1) a wide range in the cell yield 
from a spectrum of tumors; 2) a large variation in cell 
size, not only between but also within tumors; 3) a lack 
of correlation between tissue and cellular catecholamine 
content; 4) the kinetics of the decrease of cellular cate- 
cholamine content with time in culture and the inability 
of various media and serum combinations to prevent 
this decrease; 5 )  the existence of, and variation in, the 
expression of an NE uptake system; and 6) the expres- 
sion of different secretory patterns among the different 
tumor cell cultures. 
MATERIALS AND METHODS 
Materials 
Chemicals, growth factors, media, and sera were ob- 
tained from the following sources: 
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Collaborative Research, Inc., Waltham, MA: insulin, 
human transferrin, progesterone, putrescine, and selen- 
ous acid; 
Grand Island Biological Co., Grand Island, NY: Mini- 
mum Essential Medium with D-valine (MEM D-VAL); 
HiClone Laboratories, Logan, UT: Fetal calf serum 
(FCS) and plasma derived swine serum; 
K.C. Biological, Lenexa, KS: Minimum Essential Me- 
dium (MEM), Dulbecco’s Modified Eagle’s, Ham’s F12, 
and penicillidstreptomycin; 
New England Nuclear, Boston, MA: Zeuo-[ring-2,5,6- 
3HJNE with a specific activity of 40 to 60 Ci/mmoll; 
UpJohn Diagnostics Inc., Kalamazoo, M I  Cat-A-Kit” 
radioenzymatic assays; 
Sigma Chemical Co, St. Louis, MO: Collagenase (Type 
I, 130 to 250 units/mg; Type V, 300 to 500 units/mg), 
DNAase (200 to 300 Kuntz unitdmg), trypsin (9,000 to 
12,000 BAEE unitdmg), Eevo-NE, Zeuo-epinephrine (E), 
ascorbic acid, Percoll’”, acetylcholine chloride, N-2-hy- 
droxyethylpiperazine-N’-Z-ethanesulfonic acid (HEPES), 
and cytosine arabinoside; 
Vanguard International, Neptune, N J  Four-well Nunc 
Multiwell plates. 
All other reagents were analytical grade or higher 
purity. 
Patients and collections of surgical specimens 
Tumor tissue was obtained under aseptic conditions 
from 17 patients during surgery at University Hospital 
(Ann Arbor, MJJ. One surgical specimen was obtained 
from a patient at Henry Ford Hospital (Detroit, MI). The 
ten male patients and eight female patients ranged in 
age from 10 to 64 years at the time of surgery. Eight of 
the tumors were extra-adrenal and ten were intra-adre- 
nal. Each tumor was diagnosed as a typical pheochro- 
mOcytOma from multiple histological sections by 
pathologists using accepted morphological criteria. 
In the operating room, the intact tumor was placed in 
a sterile, ice cold Ca2+, M2+-free Locke’s solution for 
transport to pathology, where the tissue was weighed 
and approximately one-fourth to one-half retained for 
histologic evaluation. The balance of the tumors (1.5 to 
45 g) were transported in the same ice cold, sterile solu- 
tion to our laboratory. Transit time was usually less 
than 30 min from the operating room to our laboratory 
but was one hr when the tumor was obtained from 
Henry Ford Hospital. 
Preparation, maintenance, and characterization of 
cultured cells 
Tumor tissue was weighed, freed of connective tissue 
including capsule, and minced into pieces approximately 
2 x 2 mm. The minced tissue was placed in a sterile 
beaker containing 50 to 100 ml of Ca2‘, M2+-free 
Locke’s solution and shaken in a Dubnoff metabolic 
shaker at 125 oscillations per min at 37°C for two 20- 
min periods to remove red blood cells. Subsequently, the 
tissue was incubated with a collagenase solution in the 
Ca2+, M2+-free Locke’s solution, for four to six diges- 
tions of 40 to 50 min each. The collagenase solution, 
approximately 0.05%, consisted of two parts of !Pype V 
collagenase, adjusted to represent a constant activity of 
300 units/mg, and one part of Type I collagenase, ad- 
justed to represent a constant activity of 200 unitslmg. 
After the first digestion with collagenase, we added ap- 
proximately 15% of a 0.25% trypsin solution to succeed- 
ing digestions. The digestion solutions contained 0.05 to 
0.10 mg/ml of DNAase. Red blood cells and cellular 
debris were separated from the tumor cells by isopync- 
notic centrifugation on a preformed Percoll‘” gradient, 
which was formed using the parameters of Kilipatrick et 
al., (1980). Since we found that forming the gradient 
with the cells in situ destroyed 50 to 60% of the cells, we 
added the cellular digest to the top of the gradient before 
centrifuging them through the gradient at 450g for 10 
min. Freshly dispersed cells were plated at densities o€ 
0.4 to 0.8 x lo6 cells per well in Nunc Multiwell plates 
and maintained, except as noted, in MEM supplemented 
with 15% FCS, penicillin (100 units/ml), and steptomy- 
cin (100 pglml). Fibroblast growth was routinely inhib- 
ited by the addition of 10 pM cytosine arbinoside. The 
cells were maintained at 37°C in a humidified incubator 
(Heraeus) under a C0z:air (595) atmosphere and al- 
lowed to adapt to culture for four days prior to starting 
an experiment. After this adaptation period, the me- 
dium was changed every second or third day. At 24 hr 
prior to commencing an experiment, the medium was 
replaced with fresh medium without cytosine 
arabinoside. 
In order to determine whether the presence or absence 
of the anti-mitogen cytosine arabinoside, serum from 
different species, or more “nutrients” in the medium 
could effect cellular catecholamine levels, cells from pa- 
tient 3 were maintained in four different media for 14 
days. In this experiment, cells, initially plated in MEM 
plus FCS with cytosine arabinoside, were either main- 
tained in that medium or changed 12 hr later to (1) 
MEM plus FCS, (2) MEM D-VAL with 5% plasma de- 
rived swine serum, or (3) the Nz medium of Bottenstein 
and Sat0 (1979). The latter medium consists of a 1:P 
mixture of Ham’s F12 and Dulbecco’s Modified Eagle’s 
supplemented with 15 mM HEPES, 5 pg/ml insulin, 100 
pg/ml transferrin, 20 nM progesterone, 100 pM putres- 
cine, and 30 nM selenium. 
The cells were examined by several techniques to as- 
sess viability, morphologic appearance, cell size, and 
catecholamine content. Cell viability was greater than 
90%, as determined by trypan blue exclusion when the 
cells were plated and at the time of experiments. We did 
not observe significant cell lost during the experimental 
period. Cell loss was determined by centrifuging the 
“old” medium, removed during medium changes, and 
counting the number of cells removed at each change. 
Total cell loss (sum of “live” and “dead” cells) was less 
than 0.5% at any medium change; therefore, the maxi- 
mal theoretical cell loss that could occur during a 12- 
day experimental period would be 2% or less. Calcula- 
tions based on cell number were not corrected for this 
small cell loss. In the experiment with different media 
(Table 11, when the cell medium was changed at 12 hr, 
we anticipated that the cells might be loosely attached, 
but cell loss was less than 0.5%. Since there was no 
significant cell loss, cell viability, a t  the time of experi- 
mentation, was determined by adding trypan blue di- 
rectly to the culture wells. General cell morphology was 
visualized and photographed using an inverted Nikon 
phase-contrast microscope. Histofluorescent (De La Torre 
and Surgeon, 1976) photomicroscopy (Leitz Ortholane- 
355 nm excitation and 455 nm emission) was used to 
assess the purity of the cell preparation and to permit 
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an accurate measurement of pheochromocytoma cell 
size. Using photomicrographs, 25 to 50 fluorescent, cat- 
echolamine containing cells per dispersion were mea- 
sured. Perchloric acid cell extacts were routinely assayed 
for E and NE using the differential fluorometric assay 
technique of Anton and Sayre (1962). In some experi- 
ments, cell dopamine, in addition to E and NE, content 
was determined using the Cat-A-Kit’”, a modification of 
the radioenzymatic technique of Passon and Peuler 
(1973). Prior to mincing the tissue for a cell dispersion, 
several 100 to 200 mg samples of the tumor were set 
aside for assay of tissue catecholamine content; the tis- 
sue was homogenized with nine volumes of 0.4 N per- 
chloric acid, and the 20,OOOg supernatant was assayed 
by the differential fluorometric or radioenzymatic assay. 
Catecholamine content was expressed as nmoV1O‘ cells 
and pmolig wet weight tissue. 
Incubation conditions for ’H-NE uptake 
The uptake protocol and conditions have been de- 
scribed previously (Jaques et al., 1984; Tobes et al., 1985). 
Briefly, 4 to 12 days post-dispersion, the tissue culture 
plates were placed in a 37°C water bath or an ice water 
bath (0.5 to 1.5”C). Fifteen min prior to commencing the 
uptake study, the MEM culture medium was removed 
and the cells were preincubated, at either temperature, 
with 0.5 ml HEPES buffered Krebs Ringer Glucose (H- 
KRG), containing 1 mM ascorbic acid adjusted to a final 
pH of 7.35. Following the pre-incubation, the cells in 
each well were incubated with 0.30 ml H-KRG contain- 
ing 1.0 pM 3H-NE. At the end of the incubation period, 
the plates were placed on ice, the 3H-NE containing H- 
KRG was removed, and the cells were washed twice. 
The 3H-NE taken up by the cells was extracted with 
trichloroacetic acid, which, following the addition of 
scintillant, was counted in a Beckman LS 7500 liquid 
scintillation system for 10 min or to a 2 Sigma error of 
0.5%. 
The 37°C incubations were done in quadruplicate, 
while the 0°C incubations were done in duplicate. The 
total uptake was determined by correcting the uptake 
at 37°C for nonspecific uptake at 0°C. The uptake of 1.0 
p M  NE at 37°C was linear for 20 min or more in all 
experiments. Uptake was standardized as pmolil0‘ cells/ 
10 min because cell numbers, as well as the incubation 
time with different cell preparations, varied. Each ex- 
periment was repeated at least once, usually 3 to  5 days 
after the initial experiment; the results of single experi- 
ments are presented. Each data point represents the 
mean of quadruplicate values f the standard deviation. 
In order to determine whether fibroblast “contamina- 
tion” could significantly effect the estimation of 3H-NE 
uptake by pheochromocytoma cells, a pure preparation 
of fibroblasts isolated from a dispersion of the tumor 
from patient 14 was plated in the Nunc Multiwell plates. 
Five days later, when the cell monolayer was confluent, 
the uptake of 3H-NE by these fibroblast cells was deter- 
mined as described above but was expressed as pmoL’ 
well, since the confluent culture yielded only 67,000 
cells/well. 
Release of 3H-NE and endogenous catecholamines 
At 4 to 12 days post-dispersion, cells were preloaded 
with 3H-NE by incubating the cells with 0.30 ml H-KRG 
containing 1.0 pM 3H-NE for a 30- to 45- min period, 
during which uptake was linear. At the end of this 
period, the cells were washed twice with one ml of 
HEPES buffered-Locke’s solution and then washed fur- 
ther by incubating for two 10-min periods in fresh 
Locke’s solution (Kilpatrick et al., 1980). Following the 
removal of the last wash, the cells were incubated for 10 
rnin with 0.64 ml of Lock‘s solution, either in the pres- 
ence (stimulated release) or absence (basal release) of 
100 p M  acetylcholamine. At the end of this period, both 
cell and media content of 3H-NE were determined. The 
medium was transferred directly to a scintillation vial, 
scintillant added, and the mixture counted. The cell 
radioactivity was extracted with trichloroacetie acid and 
counted as described above. Release is expressed as a 
percentage of the total radioactivity within the cell sys- 
tem, i.e., radioactivity recovered in the medium divided 
by the sum of radioactivity in the medium and cells. The 
results of a single experiment are presented; each data 
point represents the mean f the standard deviation. All 
steps of the experimental protocol, preloading of 3H-NE, 
washes, and release were carried out a t  37°C. 
The release of endogenous catecholamines was deter- 
mined following the same experimental protocol. How- 
ever, quantitation of cell and medium catecholamines 
using either of the two catecholamine assays required 
that the media be made 0.05 N perchloric acid. There- 
fore, 0.013 ml of 2.5 N perchloric acid was added to the 
0.64 ml of the stimulus or basal release solution re- 
moved from the incubation well. Cell catecholamines 
were extracted with 0.5 ml of 0.4 N perchloric acid in 
Locke’s solution, which was then diluted to 0.05 N prior 
to assay. Standard curves for the fluorometrie assay 
were generated using authentic E and NE. Cell and 
medium catecholamine content was calculated as nmoli 
lo6 cells. Release was expressed as a percentage of the 
total E and NE in the medium divided by the total 
within the cell system. Differences between means were 
determined using Student’s t-test. 
RESULTS 
Cell yield, cell size, and cell morphology 
The cell yield from the 18 pheochromocytomas was 
quite variable; 73% of the tumors yielded 1.0 to 13.8 x 
lo6 cells/g wet weight of tissue, while the balance yielded 
19.5 to 61.6 x lo6 cells/g wet weight of tissue. There was 
no relationship between the cell yield and the anatomi- 
cal location of the tumor. 
When first plated, the cells appeared as round, individ- 
ual, phase-dark, epithelial-like cells (Fig. 1A) when vis- 
ualized with phase contrast microscopy. Cell size, both 
within and between tumors, varied significantly. A five- 
fold variation in cell diameter, from the tumor disper- 
sion of patient 1, is observed within a single microscopic 
field in Fig. 1B ( x 375). Figure 2 illustrates the variabili- 
ity, and general asymmetric distribution, of cell size 
(diameter) within six tumors. The cell size distribution 
in tumors from patients 1 and 11 (Fig. 2A and 2E) 
approximate a normal distribution, although clearly the 
most common cell sizes were different: 20 to 30 pm for 
patient 1, but only 10 to 15 pm for patient 11. In contrast, 
the distribution of cell size in tumors from patients 2, 81 
and 15 Pig. 2B, 2D, and 2F respectively) was skewed 
toward the smaller tumor cells (5 to 10 pm in diameter 
for patient 8, and 10 to 15 pm in diameter for patients 2 
and 15). Tumor cells from patient 5 (Fig. 2C) exhibited a 
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Fig. 1. Photomicrographs of human pheochromocytoma cells in cul- 
ture. A: phase contrast micrograph of cells from patient 11 at the time 
of plating ( ~ 7 2 5 ) ;  the arrow indicates a cell approximately 4.8 pm in 
diameter. B: glyoxylic acid treatment of cells from patient 1, illustrat- 
ing a five-fold range in size of fluorescent, catecholamine containing 
cells at  day 10 (~3751; the arrow indicates a cell approximately 5.0 pm 
in diameter. C: clumping or colony formation of fluorescent catechol- 
amine containing cells of patient 11 at day 5 ( ~ 3 9 0 ) .  D: phase contrast 
micrograph of spontaneously occurring, axon-like processes of cells 
from patient 11 at day 60 (X  150). 
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Fig. 2. Frequency, in percent, of fluorescent, catecholaminecontain- 
ing cells grouped by 5 pm intervals in cell diameter. The small letters 
on the abscissa represent 5 pm divisions of cell size: a = 5 to 9, b = 10 
to 14, c = 15 to 19, d = 20 to 24, e = 25 to 29, f = 30 to 34, g = 35 to 
39, h = 40 to 45, and i = 46 to  50. A cells from patient 1; B: cells from 
patient 2; C: cells from patient 5; D. cells from patient 8; E: cells from 
patient 11; and F: cells from patient 15. 
very non-uniform size distribution and the largest range 
in cell size (from 10.7 to 47.1 pm in diameter). Examples 
of the small cells, approximately 5 pm in diameter, as 
visualized by phase-contrast and histofluorescent mi- 
croscopy, are indicated with arrows in Fig. 1A and 1B. 
The pheochromocytoma cells became firmly attached 
after three to four days in culture. The round cells fre- 
quently coalesced into clumps or groups (Fig. 1C) and 
flattened somewhat as the cell membranes become less 
distinct. When pheochromocytoma cells in maintenance 
and proliferation experiments were maintained in cul- 
ture for extended periods, they often assumed a polygo- 
nal or stellate shape. When pheochromocytoma cells 
were maintained in culture for 28 days or more, 9 of 17 
spontaneously developed long axon-like processes (Fig. 
1D). This occurred as early as 5 days after plating and 
was delayed for as long as 65 days. Within these nine 
long-term experiments, the median time to the appear- 
ance of processes was 20 days. In these experiments, the 
appearance of a polygonal or stellate cell conformation, 
which often preceded the appearance of the axon-like 
processes, usually occurred at lower plating densities 
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Fig. 3. Relationship of pheochromocytoma tissue catecholamine (E 
plus NE) content &moVg wet weight) to cell catecholamine (E plus NE) 
content (nmol/106 cells), at day 5 of culture (N=15). 
and/or after passaging the cells several times. However, 
in the "short term" studies reported here, the cells 
maintained a spherical shape. 
Tissue and cell catecholamine content 
Both tissue and cell catecholamine content, which was 
predominantly E and NE, varied widely from tumor to 
tumor. The sum of tissue E plus NE content varied from 
0.17 to 77.3 pmol/g wet weight. NE was the principle 
catecholamine in most tissues and cell extracts. Nine of 
the ten intra-adrenal pheochromocytomas contained 
both E and NE, while one contained only NE. Seven of 
the eight extraadrenal tumors contained only NE, while 
one had a small amount of E, approximately 1% of the 
sum. The sum of cell E and NE content varied 224-fold, 
from 0.4 to 89.5 nmol/106 cells at day 5 in culture. The 
sum of tissue E and NE varied 326-fold, from 0.2 to 65.2 
pmol/g wet weight. However, there was a low correlation 
(r = 0.636) between tissue and cell content of these 
catecholamines (Fig. 3); the correlation was not im- 
proved by the inclusion of cellular dopamine content or 
when only the NE content of cell and tissue was 
compared. 
The cellular content of catecholamines in cultured tu- 
mor cells decreased with time in all cultures. With one 
exception (Table 1, patient 31, the decrease in cellular 
NE content was linear, as illustrated in Figure 4A and 
4B. In cells capable of synthesizing E, this catechol- 
amine, without exception, declined linearly with time in 
culture (Fig. 4B); the inability to synthesize E did not 
change with time in culture (Fig. 4A). Since the decline 
of cellular E and NE might have been due to an inability 
of the cells to hydroxylate dopamine, these levels were 
measured over the duration of two cultures. The cellular 
do amine levels were stable, averaging 6.0 & 0.9 nmoU 
10 cells over the 12-day culture period of cells from 
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(days) in culture. A cells derived from an intra-adrenal tumor from mln) to celhlar catecholamine content (moY106 cells) at day 5 of 
patient 18; NE and E cell content. B: cells derived from an intra- 
adrenal tumor from patient 11; NE and E cell content. 
Cellular catecholamine (E and NE) content, expressed as nmoll 10 g ’  cells, of cultwed pheochomocytoma cells, as a function of tirne Fig. 5. Relationship ofthe uptake of 1.0 pM 3H-NE (pmol/106 cells/lO 
culture, as determined in cultured cells from 13 pheochromocytomas. 
TABLE 1. Catecholamine content (E and NE) of pheochromocytoma cells from patient 3 on days 1,3,7, and 13, post-plating, when maintained 
in one of four different media’ 
Cell catecholamines (nmol/106 cells) Percentage loss 
by Day 134 
Day 1 Day 3 Day 7 Day 13 of catecholamines 
Medium E NE E NE E NE E NE 
~ _ _  
MEM + 15% FCS + 3.6 98.8 1.7 67.4 0.36 27.6 0.0 13.03 87.3 
- 0.4 34.6 0.1 11.2 89.0 MEM + 15% FCS - 
N’ Medium’ 1.5 48.1 0.5 22.2 0.0 12.3 88.0 




‘Cells were plated at 0.69 x lo6 cells/well in MEM + 15% FCS + cytosine arabinoside. Twelve hr later, this medium was carefully replaced with fresh MEM + FCS 
+ cytosine arabinoside or one of the other media. No cells f<O.O5%) were found in the medium that was removed at 12 hr or at subsequent medium changes; see 
Materials and Methods. The reported catecholamine values are the mean of two determinations. 
ZDefined medium of Bottenstein and Sat0 (1979). See Materials and Methods. 
3Day 14 value. 
4E plus NE: (Day 1 - Day 13)/Day 1 x 100. 
culture period of cells from patient 11. In both cultures, 
dopamine was a relatively minor component of total 
catecholamine content, representing only 14% and 5%, 
respectively, of the total cellular catecholamines at day 5. endogenous E and NE 
In the cells from patient 3 (Table 11, the decline in Uptake of 1.0 p M  3H-NE varied more than 230-fold 
cellular E and NE was not prevented by the presence or (0.2 to 46.2 pmol/106 cells/lO min) between 16 different 
absence of cytosine arabinoside, or replacement of FCS cell preparations. There was a poor correlation between 
with the hormonally defined N 2  medium. The decrease 3H-NE uptake and the cellular content of E plus NE 
in cellular catecholamines was least when the FCS was (Fig. 5), and E or NE alone (r < 0.243). Additionally, no 
replaced with plasma-derived swine serum. In none of correlation was found between 3H-NE uptake and the 
these cultures was the decline in cellular catechol- “most common” cell size (data not shown). Although 
amines related to a decline in cell viability, which was 
greater than 90% by trypan blue exclusion at all times. 
Uptake and release of 3H-NE-relationship to 
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TABLE 2. Basal and acetylcholine (ACh) stimulated release of preloaded 3H-NE and endogenous 
catecholamines from pheochromocytoma cells’ 
Patient f ACh 3H-NE2 E plus NE3 Cell age4 
1 + 14.4 f 1.2* (3) 27.9 (2) 5 
9 + 20.6 f 0.5* (3) 8.6 f 1.2* (4) 5 
- 8.2 f 1.3(3) 22.4 (2) 
- 3.3 f 0.5* (3) 3.1 It 0.5 (4) 
13 + 11.0 rt 1.8 (4) 20.3 f 2.5” (3) 8 
18 + 43.3 f 2.9* (4) 11.5 f 2.5* (4) 13 
- 13.1 f 2.0 (4) 12.2 f 1.5 (3) 
- 36.7 f 1.2 (4) 1.7 f 0.4 (4) 
’Release is expressed as a percentage of total E and NE in the medium divided by the total within the cell system. The 
cells were treated with buffer plus 100 pM ACh (+) or buffer alone (-1 for 10 min. The numbers in parentheses indicate 
the number of wells per treatment group. 
2Cells were preloaded with 1.0 p M  3H-NE for 30 to 45 min, washed twice, then washed further with two 10-min 
incubation periods prior to the addition of buffer plus ACh or buffer alone. 
3Cells assayed for the release of endogenous catecholamines (E plus NE1 were handled in parallel with those assayed for 
release of preloaded 3H-NE. 
*Number of days in which the cells were maintained in culture prior to performing the release experiment. Release of 
preloaded 3H-NE and the endogenous catecholamines was determined on the same day with the same solutions. 
Statistically different than basal release; p < 0.05. 
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cellular catecholamine content declined with time in 
culture, the uptake of 3H-NE (pmoV106 celldl0 min) 
remained stable or increased. For example, uptake of 
1.0 ph4 3H-NE by .the cells from patient 18 remained 
stable (3.3 & 0.9 on day 5 of culture and 4.6 & 0.4 on 
day lo), while cellular catecholamine levels declined 
60% over this same period (Fig. 4A). Uptake of 3H-NE 
by the cells from patient 11 increased nearly 50% be- 
tween days 5 and 9, while cellular catecholamine levels 
declined 33% over this same time period (Fig. 4B). The 
contribution of contaminating fibroblasts to the deter- 
mination of 3H-NE uptake by pheochromocytoma cells 
was assessed by growing isolated fibroblasts from pa- 
tient 14 to confluence; under these conditions, the up- 
take of 3H-NE by the fibroblasts was 0.07 pmol/well/lO 
min, which was significantly less than the uptake of 3H- 
NE by all but one tumor cell culture. 
Release, either basal or acetylcholine stimulated, of 
the endogenous catecholamines and preloaded 3H-NE 
was different between the different cell cultures. The 
basal and acetylcholine stimulated release of preloaded 
3H-NE and endogenous catecholamines from the cells of 
four tumors is shown in Table 2. Within these four cell 
cultures, the basal release of preloaded 3H-NE varied 
more than ten-fold (3.3 to 36.7%); in fact, the basal 
release of preloaded 3H-NE from the cells of patient 18 
was greater than the stimulated release of preloaded 
3H-NE from the cells of the other three tumors. The 
basal release of endogenous E and NE varied 14-fold, 
from 1.6 to 22.4%. As with the release of preloaded 3H- 
N E ,  the basal release of the endogenous catecholamines 
from the cells of one tumor (patient 1) was greater than 
the acetylcholine stimulated release of endogenous cat- 
echolamines from the cells of the other three tumors. 
Acetylcholine increased the release of preloaded 3H-NE 
more than six-fold over the basal rate from the cells of 
patient 9, but it had no stimulatory effect upon the 
release of preloaded 3H-NE from the cells of patient 13. 
The acetylcholine stimulated release of endogenous cat- 
echolamines also showed a gradation in release; nearly 
a seven-fold increase from the cells of patient 18 to a 
very minimal response from the cells of patient 1. There 
was no consistent parallel between the release, whether 
basal or acetylcholine stimulated, of preloaded 3H-NE 
and the endogenous catecholamines. 
DISCUSSION 
During the past 20 years, only a handful of investiga- 
tors have cultured cells from a limited number of human 
pheochromocytomas. Of the 12 investigations, 9 studied 
cells from only one or two of these tumors. We have 
cultured cells from 18 pheochromocytomas and provide 
new observations and insights on: 1) tumor cell yield, 2) 
the variation of cell size within and between these tu- 
mors, 3) cell morphology in culture, 4) the lack of corre- 
lation between cell and tissue catecholamine content, 5) 
the kinetics of the decrease of cellular catecholamine 
with time in culture and the inability of different media/ 
serum combinations to prevent this decrease, 6) the ex- 
istence and variability in the expression of an NE up- 
take system, and 7) the variability in basal and 
acetylcholine stimulated release of endogenous catechol- 
amines and preloaded 3H-NE. 
The cell yield from the 18 pheochromocytomas varied 
more than 70-fold, although it appeared that there were 
“high” and “low” yield types of tumors. This variability 
probably reflects the heterogeneity of these tumors, 
since, in our hands, dispersions of the more homogene- 
ous bovine adrenomedullary tissue exhibit only a two- 
fold variation in cell yield (Jaques and Tobes, unpub- 
lished observation). 
Within a given tumor, a diversity of cell size was 
observed (Fig. 2). We used histofluorescent microscopy 
to identify the catecholaminecontaining pheochromocy- 
toma cells and observed a three- to seven-fold variation 
in cell diameter within tumors. The maximal variation 
in cell diameter between all tumors was ten-fold 4.8 to 
47.1 pm. This represents a far greater variation than 
reported by Tischler et al. (1976), which described pheo- 
chromocytoma cells as “... 15 to 20 pm in diameter.” We 
found that the “most common” size of cells within a 
tumor could occur anywhere within the range of cell size 
for that tumor, i.e., cell size within a tumor seldom 
followed a Gaussian distribution. In nearly all cell dis- 
persions, five of the six illustrated in Fig. 2, we observed 
the occurrence of a population of “small” cells, 5 to 6 pm 
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in diameter, which is the size of the catecholamine- 
containing, small, intensely fluorescent (SF) cells lo- 
cated in sympathetic ganglia (Eranko, 1976; Kanerva 
and Hervonen, 1976). The significance of the variation 
of cell size and the presence of a population of “small” 
cells within these tumors is unknown; the “most com- 
mon” cell size did not correlate with any of the biochem- 
ical characteristics that were examined. 
In contrast to other investigators (Pfragner and Wal- 
ser, 1980; Tischler et al., 1976, 1984; Nishihira et al., 
19801, we observed spherical cells more frequently than 
a polygonal or stellate conformation. Clumping or %01- 
any" formation of the round, as well as of the stellate 
cells, occurred frequently. Transformation of the round 
cells to a polygonal or stellate shape, which was not 
common, usually occurred after 12 to 30 days in culture 
and usually preceded the development of axon-like pro- 
cesses. Processes developed in 9 to 17 long term cultures; 
this occurred as early as day 5 and was delayed for as 
long as 65 days. We were not able to determine, from a 
retrospective analysis of the data, whether or not the 
appearance of the axon-like processes reflected differ- 
ences in the cell density, number of passages, an inter- 
action with the different substrates (plastic, collagen, or 
polylysine), nerve growth factor synthesis by fibroblasts 
eoung et al., 19751, or of the morphologic potential of 
the cells themselves. 
Although differences in pheochromocytoma tissue cat- 
echolamine content have been reported (Winkler and 
Smith, 1968; Blaschko et al., 1968; Wrzolkowa et al., 
1975; Feldman et al., 1979; Feldman, 1981) and catechol- 
amine values from five tumors at day 0 were reported 
(Tischler et al., 1984), tissue and cell catecholamine lev- 
els have not previously been evaluated in parallel. We 
found that both tissue and cell catecholamine content (E 
plus NE) varied widely, 326- and 224-fold, respectively, 
and that there was a poor correlation between cell and 
tissue content. This lack of correlation was not improved 
by comparing only E or only NE. Possible explanations 
for this poor correlation are: 1) the heterogeneity of the 
tissue relative to the “homogeneity” of the cell prepara- 
tion; 2) different rates, between tumors, of decline of 
cellular catecholamines in culture; or 3) changes in the 
capacity of the cells to synthesize and lor store catechol- 
amines when they are maintained in culture. Dopamine 
appeared to be a minor component of the total catechol- 
amine content within these cells, and its inclusion in 
cell catecholamine content did not improve the lack of 
correlation between tissue and cellular catecholamine 
content. 
The determination of the kinetics of the decline in 
cellular E and NE with time in culture codirms and 
expands the report of Tischler et al. (19841, which de- 
scribed an 87 to 99% decrease in cellular catecholamine 
content, per culture dish, at day 21 relative to day 0. We 
explored several possible explanations for the decrease 
in cellular catecholamines with time in culture. We did 
not observe a decrease in cell number or viability with 
time in culture. Tischler et al. (1984) suggested that 
these factors were partially responsible for the decrease 
in cellular catecholamines that they observed. It seems 
likely that the cell loss described by Tischler et al. (1984) 
is a function of cell density andor cell-to-cell interaction. 
Our cells were plated at a density of 200,000 to 400,000 
cells per cm2. Their cells were plated in petri dishes of 
unstated size. If it is assumed that they used 35 mm 
petri dishes, the maximal cell density in any of their 
cultures would have been 18,000 cells per cm2, a cell 
density, minimally, 10- to 20-fold less than in our exper- 
iments. We have also found that we “lose” cells at these 
low plating densities. 
The stable uptake of 3H-NE over time in culture and 
the low and relatively stable levels of dopamine with 
time in culture, which Tischler et al. (1984) also ob- 
served, suggests that the time-dependent decrease in 
cellular E and NE content was not related either to an 
inability of the cells to take up NE or to convert dopa- 
mine to NE. The latter observation is in contrast to the 
findings in adrenomedullary cell systems when cellular 
dopamine was found to increase as E and NE declined 
(Unsicker, 1983). We also considered the possibility that 
the decline of cellular catecholamines might be due to: 
1) the absence of serum or medium factors required for 
catecholamine synthesis andor storage; 2) inhibitory 
factors that might be present in the serums; or 3) cyto- 
sine arabinoside, which might inhibit this cell function 
(Table 1). The loss of cellular E and NE when the cells 
were maintained in MEM plus FCS with or without 
cytosine arabinoside was similar, indicating that this 
anti-mitogen had no effect on catecholamine content. 
The presence of more amino acids, nucleic acids, vita- 
mins, and co-enzymes, or the lack of serum factors in 
the neuronal specific Nz medium (Bottenstein and Sato, 
1979; Bottenstein, 1983) did not affect the rate of cate- 
cholamine decline relative to the two MEM plus FCS 
media. The loss of cellular E and NE was least when the 
cells were maintained in MEM D-VAL with plasma- 
derived swine serum, suggesting a species effect of the 
serum or an inhibitory effect of MEM D-VAL upon fibro- 
blast growth (Gilbert and Migeon, 1975; Dickinson and 
Slakey, 1982). However, all of these differences were 
small and do not suggest a causative association. On the 
basis of these experiments, it appears that the require- 
ments for maintaining cellular catecholamine levels in 
culture are quite different than those for maintaining 
other cell functions such as a stable rate of 3H-NE up- 
take, the ability to exclude trypan blue, or the ability to 
synthesize axon-like processes. 
Although Anderson et al. (1973) described the in vivo 
uptake of ‘*C-dopamine by a presumed catecholamine 
uptake mechanism in human pheocromocytoma, we pro- 
vide the first direct evidence of an NE uptake mecha- 
nism in this tumor. The expression of this mechanism 
varied more than 230-fold when uptake was determined 
at a concentration of 1.0 pM 3H-NE (Fig. 5). The uptake 
values at this concentration do not reflect variations in 
the amount of endogenous cellular NE concurrently se- 
creted into the medium; therefore, the “true” concentra- 
tion of NE in the medium during the assay may be 
greater than 1.0 pM. Thus, an underestimation of “real” 
uptake would be most pronounced in those cells with 
“high” basal secretion rates. However, it does not ap- 
pear that basal secretion significantly influenced up- 
take, since an inverse correlation between high basal 
secretion and low measured uptake of 3H-NE was not 
observed (data not shown). We were unable to correlate 
the 230-fold variation in the rate of 3H-NE uptake with 
variations in any of the other biochemical parameters 
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examined. The physiologic function, if any, or NE up- 
take in adrenomedullary and pheochromocytoma cells 
is not known. 
The uptake of 3H-NE by fibroblasts was very low and 
a minor source of error in all experiments except one. If 
fibroblasts had grown to total confluency (a process rou- 
tinely inhibited by the presence of cytosine arabinoside), 
fibroblast uptake of 3H-NE could have contributed to an 
over-estimation of uptake by tumor cells by 0.1 to 1.8% 
in 17 of 18 cell preparations. The determination of 3H- 
NE uptake by the tumor cells of patient 14 (0.2 pmoV106 
cells/lO min) would be over-estimated by 54% if fibro- 
blasts had grown to confluency, i.e., “real” uptake would 
be 0.2 minus 0.07 pmol/106 cells/lO min. 
Our studies demonstrate the expression of different 
secretory patterns in human pheochromocytoma cells. 
Normal adrenomedullary cells have a low rate of basal 
release, typically 3 or 4%. In these cells, acetylcholine, 
or its nicotinic agonists, normally stimulate release 
three- to seven-fold above basal levels (Hochman and 
Perlman, 1976; Lang and Perlman, 1979; Fenwick et al., 
1978; Kilpatrick et al., 1980), and the endogenous cate- 
cholamines and preloaded 3H-NE are released in paral- 
lel milpatrick et al., 1980; Trifaro and Lee, 1980). 
Although our release studies suggest that some similar- 
ities to release in normal adrenomedullary cells remain, 
release from the human pheochromocytoma cells was 
always different than the release from normal adreno- 
medullary cells with respect to at least one of the follow- 
ing criteria: 1) elevated basal release, 2) lack of response 
to acetylcholine, or 3) nonparallel release of endogenous 
catecholamines and preloaded 3H-NE (Tnblc 2). The 
basal release of endogenous catecholamines from the 
cells of patients 9 (3.3%) and 18 (1.7%) was similar to 
that of “normal” adrenomedullary cells. In contrast, the 
basal release of endogenous catecholamines in the cells 
from patients 1 and 13 (22.4 and 12.2%, respectively) 
was as high or higher than the acetylcholine-stimulated 
release in the other tumor cells or in normal adrenome- 
dullary cells (Hochman and Perlman, 1976; Lang and 
Perlman, 1979; Fenwick et al., 1978; Kilpatrick et al., 
1980). Acetylcholine stimulated the release of both the 
endogenous catecholamines and preloaded ’H-NE in 
only two of the four dispersions (patients 9 and 19). In 
the other two cell dispersions, acetylcholine did not stim- 
ulate the release of both the preloaded 3H-NE and the 
endogenous catecholamines, although it caused the re- 
lease of one or the other. The nonparallel release of the 
newly sequestered 3H-NE relative to the release of the 
older, endogenous stores of E and NE in these pheochro- 
mocytoma cells was also reported by Wilson et al. (1981) 
in cells from one tumor and is in contrast to their paral- 
lel release in normal bovine adrenomedullary cells (Kil- 
patrick et al., 1980; Trifaro and Lee, 1980). These 
observations suggest that a change in cateholamine 
storage or release pools is a common occurrence in pheo- 
chromocytoma and that this change may be a causative 
factor in the etiology of the disease. The elevated basal 
release of some of the cells was consistent with the 
hypothesis that elevated plasma catecholamines are as- 
sociated with defective storage or catecholamine synthe- 
sis mechanisms (Manger and Gifford, 1977). However, 
hyper-secretion by tumors with cells that appear to have 
“normal” basal secretion and acetylcholine responsive- 
ness must be explained by other, as yet undetermined, 
mechanisms. 
The acetylcholine-stimulated release described here 
reflects not only activation of nicotinic (Wilson et al., 
1981) and/or muscarinic (Koelle, 1970) receptors on the 
cells, but also the relative rate of metabolism of acetyl- 
choline by each tumor cell culture. Acetylcholinesterase 
activity has been described in adrenomedullary cells 
(Mizobe and Livett, 1980) and rat PC12 cells (Greene 
and Tischler, 19821, but not in human pheochromocy- 
toma tissue or cells. Although acetylcholinesterase ac- 
tivity may have been present, we did not use an 
acetylcholinesterase inhibitor because of unpredictable 
side effects, i.e., 1) these inhibitors may stimulate mus- 
carinic receptors (Taylor, 19801, and 2) 8 pM eserine 
actually inhibited acetylcholine-stimulated release of 
catecholamines from human pheochromocytoma cells 
(data not shown). A time-dependent increase in acetyl- 
cholinesterase activity partially inhibited acetylcholine- 
stimulated release in bovine adrenomedullary cells (Mi- 
zobe and Livett, 19801, and a similar phenomenon could 
confuse the interpretation of our data. However, it does 
not appear that time-dependent variations in the activ- 
ity of a putative acetylcholinesterase are responsible for 
the different secretory patterns reported here. The cells 
from patients 1,9, and 13 were of similar age (5, 5, and 
8 days respectively), while the cells from patient 18, 
which were 13 days of age, had the greatest acetylcho- 
line-stimulated release of the endogenous catechol- 
amines (Table 2). 
In summary, we have described 1) a large variation 
in cell yield bctween tumors; 2) a large variation in cell 
size, within and between tumors; 3) a lack of correlation 
between tissue and cellular catecholamine content; 4) 
the kinetics of the decrease of cellular catecholamine 
content with time in culture and the inability of various 
media and serum combinations to prevent this decrease; 
5) the existence of and variation in the expression of an 
NE uptake system; and 6) the expression of different 
secretory patterns among different tumor cell cultures. 
These studies should provide a foundation for further 
biochemical investigation of this tumor. 
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